PTEN and central nervous system cancer: Exogenous expression of PTEN in PTEN-deficient and VEGFR-2-positive LN-308 and U138MG glioma cells (Figure 2C) led to reduced VEGFR-2 mRNA and protein levels (Figure 2D), confirming a VEGFR-2-suppressive effect for PTEN.